MTB and important from FA 2 Flashcards
Panhypopituitarism - diagnostic tests - sodium
hyponatremia: common in 2ry hypothyroidism and isloated glucocorticoid underproduction
Panhypopituitarism - diagnostic tests - some older, less useful tests (only name them)
- Metyrapone: inhibits 11-beta hydroxylase –> decrease the output of the adrenal gland (normally increases ACTH
- Insulin stimulation –> normally increases GH
Panhypopituitarism - specific diagnostic test for TSH: standard blood test and confirmation
standard blood test: low tsh and thyoxine levels
abnormality confirmed with: decreased TSH response to TRH
Panhypopituitarism - specific diagnostic test for ACTH: standard blood test and confirmation
standard blood test: low ACTH + cortisol levels
abnormality confirmed with: 1. elevated baseline cortisol excludes pituitary insufficiency
2. No response with CRH
3. Normal respone to cosyntropin stimulation of the adrenal in recent disease, but not in chronic disease because of adrenal atrophy
Panhypopituitarism - specific diagnostic test for LH/FSH: standard blood test and confirmation
standard blood test: low LH, FSH and Testosterone levels
abnormality confirmed with: no confirmatory test
- maybe: no menstruation following administration of medroxyprogesterone
Panhypopituitarism - specific diagnostic test for GH: standard blood test and confirmation
standard blood test: Low GH levels (non helpful since GH is pulsatile and maximum at night)
abnormality confirmed with: 1. No response to arginin infusion 2. No response to GHRH
Panhypopituitarism - specific diagnostic test for prolactin: standard blood test and confirmation
standard blood test: low prolactin levels (not helpful)
abnormality confirmed with: no response to TRH
nephrogenic DI (NDI) - etiology
- few kidney diseases such as chronic pyelonephritis, amyloidosis, myeloma, or sickle cell anema disease will damage enough to inhibit ADH effect
- Hypercalcemia
- Hypokalemia
- drugs (lithium, demeclocycline)
The difference between central + nephrogenic DI is deermined by
respone to vasopressin (desmopressin)
(VASOPRESSIN STIMULATION TEST):
in central: urine volume will decrease and urine osm increase
in nephrogenic: no effect
nephrogenic DI - treatment
- trying to correct the UNDERLYING CAUSE
- hydrochlorothiazide
- amiloride
- prostagladin inhibitors such as NSAID
Laron syndrome - mechanism
Dwarfism: defective growth hormone receptor –> decreased linear growth
Laron syndrome - clinical feature
- short height
- small head circumference
- facies with saddle nose and prominent forehead
- delayed skeletale maturation
- small genitalia
methimazole and propylthiouracil -toxicity
- skin rash 2. agranulocytosis 3. aplastic anemia
4. hepatotoxicity (propylthiouracil) 5. teratogen (methimazol)
cinacalcet - mechanism of action / SE
sensitizes Ca2+-sensing receptor (CaSR) in parathyroid gland to circulating Ca2+ –> decreases PTH
SE: hypocalcemia
cinacalcet - clinical use
hypercalcemia due to 1ry or 2ry hyperparathyroidims
ADH antagonists
- demeclocycline
- conivaptan
- tolvaptan
demeclocycline - toxicity
- nephrogenic diabetes insibidus
- photosensitivity
- Abnormalities of bone and teeth
GH as a drug - clinical use
- GH deficiency
2. Turner syndrome
Oxytocin - clinical use
- stimulates labor
- uterine contraction
- milk let down
- controls uterin hemorrhage
octreotide - clinical use
- acromegaly 2. carcinoid syndrome 3. gastrinoma
4. glucagonoma 5. esophangeal varices (acute bleed) 6. VIPoma